Norvasc and Seroma - a phase IV clinical study of FDA data

Summary:

Seroma is reported as a side effect among people who take Norvasc (amlodipine besylate), especially for people who are male, 60+ old, also take Aspirin, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Seroma when taking Norvasc. It is created by eHealthMe based on reports of 133,505 people who have side effects when taking Norvasc from the FDA, and is updated regularly.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.

What is Seroma?

Seroma (a tumour like collection of serum in the tissues) is found to be associated with 334 drugs and 399 conditions by eHealthMe. Check the latest studies of Seroma.

On Jul, 19, 2026

133,505 people reported to have side effects when taking Norvasc.
Among them, 26 people (0.02%) have Seroma.

Among these 26 people:

What is the gender of people who have Seroma when taking Norvasc? *

female: 48 %
male: 52 %

What is the age of people who have Seroma when taking Norvasc? *

What are other drugs people take besides Norvasc? *

What are other side effects people have besides Seroma? *

Back Pain: 8 people, 30.77%
Weakness: 6 people, 23.08%
Cardiac Failure Congestive: 6 people, 23.08%
High Blood Cholesterol: 6 people, 23.08%
Pain In Extremity: 5 people, 19.23%
Stress And Anxiety: 5 people, 19.23%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 19.23%
Oedema Peripheral (superficial swelling): 5 people, 19.23%
Chest Pain: 5 people, 19.23%
Dyspnea (difficult or laboured breathing): 5 people, 19.23%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 15.38%
Breast Cancer: 3 people, 11.54%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 7.69%
Pain: 2 people, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 7.69%
Breast Cancer Recurrent: 2 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.85%
Osteoporosis (bones weak and more likely to break): 1 person, 3.85%
Joint Pain: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and have Seroma?

- Check whether Seroma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norvasc:

Norvasc (136,738 reports)

Seroma treatments and more:

Seroma (2,095 reports)

Browse all side effects of Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seroma:

Seroma (334 drugs)

Browse all the conditions that are associated with Seroma:

Seroma (399 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Norvasc) and Norvasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.